Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Bart Jacobs
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Chemicals & Drugs
Procedures
Physiology
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
46
Van Doorn, Pieter
24
Ang, Wim
23
Van der Meché, F G A
17
Endtz, Hubert
14
Geleijns, Karin
12
Tio-Gillen, Anne
10
Laman, Jon
7
Kuijf, Mark
7
Van Belkum, Alex
7
Schmitz, P I M
7
Van Rijs, Wouter
7
Willison, Hugh
6
van Koningsveld, Rinske
6
Meulstee, J
6
Gilbert, Michel
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Bart Jacobs (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Kuijf M L; Eurelings M; Tio-Gillen A P; van Doorn P A; van den Berg L H; Hooijkaas H; Stork J; Notermans N C; Jacobs B C
Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
Neurology 2009;73(9):688-95.
-
2009: Dekker Marieke J H J; van den Akker Erica L T; Koper Jan Willem; Manenschijn Laura; Geleijns Karin; Ruts Liselotte; van Rijs Wouter; Tio-Gillen Anne P; van Doorn Pieter A; Lamberts Steven W J; Jacobs Bart C
Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
Journal of the peripheral nervous system : JPNS 2009;14(2):75-83.
-
2009: de Wit M C Y; Kros J M; Halley D J J; de Coo I F M; Verdijk R; Jacobs B C; Mancini G M S
Filamin A mutation, a common cause for periventricular heterotopia, aneurysms and cardiac defects.
Journal of neurology, neurosurgery, and psychiatry 2009;80(4):426-8.
-
2008: Kuijf Mark L; Geleijns Karin; Ennaji Noureddine; van Rijs Wouter; van Doorn Pieter A; Jacobs Bart C
Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.
Journal of neuroimmunology 2008;205(1-2):110-2.
-
2008: van Doorn Pieter A; Ruts Liselotte; Jacobs Bart C
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.
Lancet neurology 2008;7(10):939-50.
-
2008: Zitman F M P; Todorov B; Jacobs B C; Verschuuren J J; Furukawa K; Furukawa K; Willison H J; Plomp J J
Neuromuscular synaptic function in mice lacking major subsets of gangliosides.
Neuroscience 2008;156(4):885-97.
-
2008: van de Geijn F E; Hazes J M W; Geleijns K; Emonts M; Jacobs B C; Dufour-van den Goorbergh B C M; Dolhain R J E M
Mannose-binding lectin polymorphisms are not associated with rheumatoid arthritis--confirmation in two large cohorts.
Rheumatology (Oxford, England) 2008;47(8):1168-71.
-
2008: Pukin Aliaksei V; Weijers Carel A G M; van Lagen Barend; Wechselberger Rainer; Sun Bin; Gilbert Michel; Karwaski Marie-France; Florack Dion E A; Jacobs Bart C; Tio-Gillen Anne P; van Belkum Alex; Endtz Hubert P; Visser Gerben M; Zuilhof Han
GM3, GM2 and GM1 mimics designed for biosensing: chemoenzymatic synthesis, target affinities and 900 MHz NMR analysis.
Carbohydrate research 2008;343(4):636-50.
-
2008: Jacobs Bart C; Koga Michiaki; van Rijs Wouter; Geleijns Karin; van Doorn Pieter A; Willison Hugh J; Yuki Nobuhiro
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
Journal of neuroimmunology 2008;194(1-2):181-90.
-
2007: Geleijns Karin; Emonts Marieke; Laman Jon D; van Rijs Wouter; van Doorn Pieter A; Hermans Peter W M; Jacobs Bart C
Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.
Journal of neuroimmunology 2007;190(1-2):127-30.
-
2007: Ruts Liselotte; van Koningsveld Rinske; Jacobs Bart C; van Doorn Pieter A
Determination of pain and response to methylprednisolone in Guillain-Barré syndrome.
Journal of neurology 2007;254(10):1318-22.
-
2007: Baar I; Jacobs B C; Govers N; Jorens P G; Parizel P M; Cras P
Campylobacter jejuni-induced acute transverse myelitis.
Spinal cord : the official journal of the International Medical Society of Paraplegia 2007;45(10):690-4.
-
2007: Ang C W; Krogfelt K; Herbrink P; Keijser J; van Pelt W; Dalby T; Kuijf M; Jacobs B C; Bergman M P; Schiellerup P; Visser C E
Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2007;13(9):915-22.
-
2007: Kuijf Mark L; Godschalk Peggy C R; Gilbert Michel; Endtz Hubert P; Tio-Gillen Anne P; Ang C Wim; van Doorn Pieter A; Jacobs Bart C
Origin of ganglioside complex antibodies in Guillain-Barré syndrome.
Journal of neuroimmunology 2007;188(1-2):69-73.
-
2007: van Koningsveld Rinske; Steyerberg Ewout W; Hughes Richard A C; Swan Anthony V; van Doorn Pieter A; Jacobs Bart C
A clinical prognostic scoring system for Guillain-Barré syndrome.
Lancet neurology 2007;6(7):589-94.
-
2007: Godschalk Peggy C R; van Belkum Alex; van den Braak Nicole; van Netten Diana; Ang C Wim; Jacobs Bart C; Gilbert Michel; Endtz Hubert P
PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.
Journal of clinical microbiology 2007;45(7):2316-20.
-
2007: Godschalk Peggy C R; Kuijf Mark L; Li Jianjun; St Michael Frank; Ang C Wim; Jacobs Bart C; Karwaski Marie-France; Brochu Denis; Moterassed Ali; Endtz Hubert P; van Belkum Alex; Gilbert Michel
Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
Infection and immunity 2007;75(3):1245-54.
-
2006: ter Meulen B C; Kros J M; Jacobs B C
Sudden death after air travel in a patient with colloid cyst.
Neurology 2006;67(6):1005.
-
2006: Geleijns Karin; Roos Anja; Houwing-Duistermaat Jeanine J; van Rijs Wouter; Tio-Gillen Anne P; Laman Jon D; van Doorn Pieter A; Jacobs Bart C
Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(6):4211-7.
-
2006: Eurelings Marijke; Notermans Nicolette C; Lokhorst Henk M; van Kessel Berris; Jacobs Bart C; Wokke John H J; Sahota Surinder S; Bloem Andries C
Immunoglobulin gene analysis in polyneuropathy associated with IgM monoclonal gammopathy.
Journal of neuroimmunology 2006;175(1-2):152-9.
-
2006: Kuijf Mark L; Ang C Wim; van Doorn Pieter A; Niesters Hubert G M; Jacobs Bart C
Presence or absence of cytomegalovirus in cerebrospinal fluid from patients with Guillain-Barré syndrome?
The Journal of infectious diseases 2006;193(10):1471-2; author reply 1472-3.
-
2006: Garssen M P J; Schmitz P I M; Merkies I S J; Jacobs B C; van der Meché F G A; van Doorn P A
Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.
Journal of neurology, neurosurgery, and psychiatry 2006;77(1):61-5.
-
2006: Godschalk Peggy C R; Gilbert Michel; Jacobs Bart C; Kramers Tessely; Tio-Gillen Anne P; Ang C Wim; Van den Braak Nicole; Li Jianjun; Verbrugh Henri A; Van Belkum Alex; Endtz Hubert P
Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
Microbes and infection / Institut Pasteur 2006;8(1):248-53.
-
2005: Kuijf Mark L; van Doorn Pieter A; Tio-Gillen Anne P; Geleijns Karin; Ang C Wim; Hooijkaas Herbert; Hop Wim C J; Jacobs Bart C
Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.
Journal of the neurological sciences 2005;239(1):37-44.
-
2005: van Sorge Nina M; van der Pol W-Ludo; Jansen Marc D; Geleijns Karin P W; Kalmijn Sandra; Hughes Richard A C; Rees Jeremy H; Pritchard Jane; Vedeler Christian A; Myhr Kjell-Morten; Shaw Chris; van Schaik Ivo N; Wokke John H J; van Doorn Pieter A; Jacobs Bart C; van de Winkel Jan G J; van den Berg Leonard H
Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms.
Journal of neuroimmunology 2005;162(1-2):157-64.
-
2005: Geleijns Karin; Laman Jon D; van Rijs Wouter; Tio-Gillen Anne P; Hintzen Rogier Q; van Doorn Pieter A; Jacobs Bart C
Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.
Journal of neuroimmunology 2005;161(1-2):183-9.
-
2005: Geleijns K; Schreuder G M Th; Jacobs B C; Sintnicolaas K; van Koningsveld R; Meulstee J; Laman J D; van Doorn P A
HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.
Neurology 2005;64(1):44-9.
-
2004: Godschalk Peggy C R; Heikema Astrid P; Gilbert Michel; Komagamine Tomoko; Ang C Wim; Glerum Jobine; Brochu Denis; Li Jianjun; Yuki Nobuhiro; Jacobs Bart C; van Belkum Alex; Endtz Hubert P
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
The Journal of clinical investigation 2004;114(11):1659-65.
-
2004: Geleijns K; Brouwer B A; Jacobs B C; Houwing-Duistermaat J J; van Duijn C M; van Doorn P A
The occurrence of Guillain-Barre syndrome within families.
Neurology 2004;63(9):1747-50.
-
2004: Geleijns Karin; Jacobs Bart C; Van Rijs Wouter; Tio-Gillen Anne P; Laman Jon D; van Doorn Pieter A
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
Journal of neuroimmunology 2004;150(1-2):132-8.
-
2004: Ang C Wim; Jacobs Bart C; Laman Jon D
The Guillain-Barré syndrome: a true case of molecular mimicry.
Trends in immunology 2004;25(2):61-6.
-
2003: Buljevac Dragan; Verkooyen Roel P; Jacobs Bart C; Hop Wim; van der Zwaan Liesbeth A; van Doorn Pieter A; Hintzen Rogier Q
Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients.
Annals of neurology 2003;54(6):828-31.
-
2003: Jacobs Bart C; O'Hanlon Graham M; Bullens Roland W M; Veitch Jean; Plomp Jaap J; Willison Hugh J
Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
Brain : a journal of neurology 2003;126(Pt 10):2220-34.
-
2003: van Sorge Nina M; van den Berg Leonard H; Geleijns Karin; van Strijp Jos A; Jacobs Bart C; van Doorn Pieter A; Wokke John H J; van de Winkel Jan G J; Leusen Jeanette H W; van der Pol W-Ludo
Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
Annals of neurology 2003;53(5):570-9.
-
2003: Overeem Sebastiaan; Geleijns Karin; Garssen Marcel P J; Jacobs Bart C; van Doorn Pieter A; Lammers Gert Jan
Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy.
Neuroscience letters 2003;341(1):13-6.
-
2002: Ang C W; Tio-Gillen A P; Groen J; Herbrink P; Jacobs B C; Van Koningsveld R; Osterhaus A D M E; Van der Meché F G A; van Doorn P A
Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.
Journal of neuroimmunology 2002;130(1-2):179-83.
-
2002: Jacobs Bart C; Bullens Roland W M; O'Hanlon Graham M; Ang C Wim; Willison Hugh J; Plomp Jaap J
Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome.
Muscle & nerve 2002;25(4):549-58.
-
2002: Ang C W; Laman J D; Willison H J; Wagner E R; Endtz H P; De Klerk M A; Tio-Gillen A P; Van den Braak N; Jacobs B C; Van Doorn P A
Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
Infection and immunity 2002;70(3):1202-8.
-
2001: Ang C W; Koga M; Jacobs B C; Yuki N; van der Meché F G; van Doorn P A
Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands.
Journal of neuroimmunology 2001;121(1-2):83-7.
-
2001: Eurelings M; Ang C W; Notermans N C; Van Doorn P A; Jacobs B C; Van den Berg L H
Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy.
Neurology 2001;57(10):1909-12.
-
2001: van Koningsveld R; Rico R; Gerstenbluth I; Schmitz P I; Ang C W; Merkies I S; Jacobs B C; Halabi Y; Endtz H P; van der Meché F G; van Doorn P A
Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curaçao.
Neurology 2001;56(11):1467-72.
-
2001: Koga M; Ang C W; Yuki N; Jacobs B C; Herbrink P; van der Meché F G; Hirata K; van Doorn P A
Comparative study of preceding Campylobacter jejuni infection in Guillain-Barré syndrome in Japan and The Netherlands.
Journal of neurology, neurosurgery, and psychiatry 2001;70(5):693-5.
-
2001: Ang C W; De Klerk M A; Endtz H P; Jacobs B C; Laman J D; van der Meché F G; van Doorn P A
Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Infection and immunity 2001;69(4):2462-9.
-
2000: Ang C W; van Doorn P A; Endtz H P; Merkies I S; Jacobs B C; de Klerk M A; van Koningsveld R; van der Meché F G
A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis.
Journal of neuroimmunology 2000;111(1-2):229-33.
-
2000: Endtz H P; Ang C W; van den Braak N; Luijendijk A; Jacobs B C; de Man P; van Duin J M; van Belkum A; Verbrugh H A
Evaluation of a new commercial immunoassay for rapid detection of Campylobacter jejuni in stool samples.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(10):794-7.
-
2000: Endtz H P; Ang C W; van Den Braak N; Duim B; Rigter A; Price L J; Woodward D L; Rodgers F G; Johnson W M; Wagenaar J A; Jacobs B C; Verbrugh H A; van Belkum A
Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.
Journal of clinical microbiology 2000;38(6):2297-301.
-
2000: Ang C W; Endtz H P; Jacobs B C; Laman J D; de Klerk M A; van der Meché F G; van Doorn P A
Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
Journal of neuroimmunology 2000;104(2):133-8.
-
2000: Ang C W; Jacobs B C; Brandenburg A H; Laman J D; van der Meché F G; Osterhaus A D; van Doorn P A
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
Neurology 2000;54(7):1453-8.
-
2000: Yuki N; Ang C W; Koga M; Jacobs B C; van Doorn P A; Hirata K; van der Meché F G
Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
Annals of neurology 2000;47(3):314-21.
-
1999: Ang C W; Yuki N; Jacobs B C; Koga M; Van Doorn P A; Schmitz P I; Van Der Meché F G
Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.
Neurology 1999;53(9):2122-7.
-
1999: Plomp J J; Molenaar P C; O'Hanlon G M; Jacobs B C; Veitch J; Daha M R; van Doorn P A; van der Meché F G; Vincent A; Morgan B P; Willison H J
Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates.
Annals of neurology 1999;45(2):189-99.
-
1998: Jacobs B C; Rothbarth P H; van der Meché F G; Herbrink P; Schmitz P I; de Klerk M A; van Doorn P A
The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study.
Neurology 1998;51(4):1110-5.
-
1998: Hoijer M A; de Groot R; van Lieshout L; Jacobs B C; Melief M J; Hazenberg M P
Differences in N-acetylmuramyl-L-alanine amidase and lysozyme in serum and cerebrospinal fluid of patients with bacterial meningitis.
The Journal of infectious diseases 1998;177(1):102-6.
-
1997: Jacobs B C; O'Hanlon G M; Breedland E G; Veitch J; van Doorn P A; Willison H J
Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides.
Journal of neuroimmunology 1997;80(1-2):23-30.
-
1997: van der Meché F G; Visser L H; Jacobs B C; Endtz H P; Meulstee J; van Doorn P A
Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups.
The Journal of infectious diseases 1997;176 Suppl 2():S99-102.
-
1997: Jacobs B C; Endtz H P; van der Meché F G; Hazenberg M P; de Klerk M A; van Doorn P A
Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
Journal of neuroimmunology 1997;79(1):62-8.
-
1997: Jacobs B C; van Doorn P A; Groeneveld J H; Tio-Gillen A P; van der Meché F G
Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
Journal of neurology, neurosurgery, and psychiatry 1997;62(6):641-3.
-
1997: Jacobs B C; Meulstee J; van Doorn P A; van der Meché F G
Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré syndrome.
Muscle & nerve 1997;20(4):446-52.
-
1997: Jacobs B C; Hazenberg M P; van Doorn P A; Endtz H P; van der Meché F G
Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
The Journal of infectious diseases 1997;175(3):729-33.
-
1996: Visser L H; van der Meché F G; Meulstee J; Rothbarth P P; Jacobs B C; Schmitz P I; van Doorn P A
Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group.
Neurology 1996;47(3):668-73.
-
1996: Jacobs B C; van Doorn P A; Schmitz P I; Tio-Gillen A P; Herbrink P; Visser L H; Hooijkass H; van der Meché F G
Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Annals of neurology 1996;40(2):181-7.
-
1996: Jacobs B C; Schmitz P I; van der Meche F G
Campylobactery jejuni Infection and treatment for Guillain-Barré Syndrome.
The New England journal of medicine 1996;335(3):208-9.
-
1995: van der Meché F G; van Doorn P A; Jacobs B C
Inflammatory neuropathies--pathogenesis and the role of intravenous immune globulin.
Journal of clinical immunology 1995;15(6 Suppl):63S-69S.
-
1995: Visser L H; Van der Meché F G; Van Doorn P A; Meulstee J; Jacobs B C; Oomes P G; Kleyweg R P; Meulstee J
Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group.
Brain : a journal of neurology 1995;118 ( Pt 4)():841-7.
-
1995: Oomes P G; Jacobs B C; Hazenberg M P; Bänffer J R; van der Meché F G
Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Annals of neurology 1995;38(2):170-5.
-
1995: Jacobs B C; Endtz H; van der Meché F G; Hazenberg M P; Achtereekte H A; van Doorn P A
Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
Annals of neurology 1995;37(2):260-4.
-
1993: Adriaansen H J; Jacobs B C; Kappers-Klunne M C; Hählen K; Hooijkaas H; van Dongen J J
Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(3):472-81.
Sign-in to see more
